The clinical significance of ABCC3 as an imatinib transporter in chronic myeloid leukaemia

Leukemia. 2014 Jun;28(6):1360-3. doi: 10.1038/leu.2014.38. Epub 2014 Jan 20.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Benzamides / pharmacology*
  • Case-Control Studies
  • Follow-Up Studies
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / metabolism*
  • Multidrug Resistance-Associated Proteins / genetics
  • Multidrug Resistance-Associated Proteins / metabolism*
  • Piperazines / pharmacology*
  • Prognosis
  • Pyrimidines / pharmacology*
  • RNA, Messenger / genetics
  • Real-Time Polymerase Chain Reaction
  • Reverse Transcriptase Polymerase Chain Reaction

Substances

  • Antineoplastic Agents
  • Benzamides
  • Multidrug Resistance-Associated Proteins
  • Piperazines
  • Pyrimidines
  • RNA, Messenger
  • multidrug resistance-associated protein 3
  • Imatinib Mesylate